Arcellx (ACLX) Stock Forecast for 2024–2028. Sell or Buy Prediction







Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…

Arcellx (ACLX) Stock Forecast for 2024–2028. Sell or Buy?

Updated: June 23, 2024 (04:52)

Sector: Healthcare

The share price of Arcellx, Inc. (ACLX) now

Latest session on the 21st of June for
Arcellx, Inc. is positive
Trading Volume: 793192
Open: 54.79 /  High: 56.32 /  Low: 53.9
What analysts predict: $79.93
52-week High/Low: $75.1 / $30.74

50/200 Day Moving Average: $53.05 / $52.45

This figure corresponds to the Average Price over the previous 50/200 days. For Arcellx stocks, the 50-day moving average is the support level today.

For Arcellx stocks, the 200-day moving average is the support level today.

Are you interested in Arcellx, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Arcellx stock price in 2024, 2025, 2026, 2027, 2028. How much will one Arcellx share be worth in 2024 - 2028?

When should I take profit in Arcellx stock? When should I record a loss on Arcellx stock? What are analysts' forecasts for Arcellx stock? What is the future of Arcellx stock? We forecast Arcellx stock performance using neural networks based on historical data on Arcellx stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Arcellx stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Arcellx shares. This happens once a day.


Historical and forecast chart of Arcellx stock

The chart below shows the historical price of Arcellx stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Arcellx stock price can be found in the table below.

Long-term forecasts by years.

The Future Unveiled: Arcellx Inc. (ACLX) Stock Forecast

In the rapidly evolving world of biopharmaceuticals, Arcellx, Inc. stands out as a beacon of innovation. Dedicated to transforming the lives of cancer patients through its pioneering adaptive immune cell therapies, Arcellx is at the forefront of a medical revolution. But with such groundbreaking advancements come questions regarding the investment opportunities in ACLX stock. How accurately can the ACLX stock forecast be predicted? And what events and factors will influence the ACLX stock price in the near future?

Deciphering the Arcellx Stock Code

Given the company’s focus on developing treatments that can be silenced, activated, and reprogrammed according to disease progression, Arcellx’s approach to cancer therapy is nothing short of revolutionary. However, when it comes to forecasting ACLX stock rates, investors find themselves navigating a complex landscape. Several factors entail the fluctuation of ACLX stock price prediction, making it a topic of significant intrigue.

Firstly, clinical trial results and regulatory approvals play a massive role in shaping the Arcellx stock forecast. Positive outcomes can lead to surges in investor confidence, driving the ACLX stock price target upwards. Conversely, any setbacks could result in the ACLX stock being down, challenging the notion of ACLX being a good stock to buy.

Additionally, market sentiments and overall industry trends significantly impact whether ACLX stock is a buy or sell decision for investors. With the rapid advancements in cancer therapy, Arcellx must stay ahead of its competitors to maintain and improve its stock valuation.

In conclusion, while predicting the exact ACLX stock price prediction remains challenging, monitoring the company’s research progress, regulatory news, and market trends can provide valuable insights. The question of “is ACLX a good stock to buy” ultimately depends on the investor’s confidence in Arcellx’s innovative approach to cancer therapy and their appetite for the inherent risks of investing in the biopharmaceutical sector. As we look into the future, one thing is clear: Arcellx is a name that could very well redefine cancer treatment and, consequently, its stock value.

Arcellx daily forecast for a month

Date Target Pes. Opt. Vol., %
Jun 25 56.61 55.95 57.09 2.03
Jun 26 57.39 56.72 58.74 3.55
Jun 27 56.57 56.16 57.77 2.87
Jun 28 55.94 54.61 57.17 4.67
Jun 29 56.43 55.75 57.21 2.61
Jun 30 57.63 57.02 59.01 3.49
Jul 01 56.97 56.61 57.81 2.11
Jul 02 56.44 55.19 57.00 3.28
Jul 03 56.68 55.47 57.95 4.48
Jul 04 55.22 54.04 56.14 3.89
Jul 05 54.07 52.82 55.24 4.58
Jul 06 55.47 54.64 56.58 3.56
Jul 07 57.10 56.48 57.94 2.58
Jul 08 57.51 56.87 58.84 3.46
Jul 09 58.99 57.76 60.30 4.41
Jul 10 60.20 59.08 60.83 2.97
Jul 11 59.78 59.32 60.57 2.12
Jul 12 61.40 60.59 62.23 2.71
Jul 13 60.14 59.35 60.85 2.52
Jul 14 58.43 57.96 59.13 2.03
Jul 15 58.54 57.89 59.90 3.49
Jul 16 58.43 57.92 59.73 3.12
Jul 17 59.67 58.33 60.93 4.45
Jul 18 59.62 58.99 60.48 2.52
Jul 19 59.53 58.48 60.48 3.42
Jul 20 59.41 58.39 60.49 3.60
Jul 21 59.85 58.70 60.70 3.40
Jul 22 59.74 58.79 60.17 2.35
Jul 23 60.51 59.12 61.33 3.75
Jul 24 59.19 57.88 60.54 4.60

Arcellx Daily Price Targets


Arcellx Stock Forecast 06-25-2024.

Forecast target price for 06-25-2024: $56.61.
Positive dynamics for Arcellx shares will prevail with possible volatility of 1.993%.
Pessimistic target level: 55.95
Optimistic target level: 57.09

Arcellx Stock Forecast 06-26-2024.

Forecast target price for 06-26-2024: $57.39.
Positive dynamics for Arcellx shares will prevail with possible volatility of 3.430%.
Pessimistic target level: 56.72
Optimistic target level: 58.74

Arcellx Stock Forecast 06-27-2024.

Forecast target price for 06-27-2024: $56.57.
Negative dynamics for Arcellx shares will prevail with possible volatility of 2.791%.
Pessimistic target level: 56.16
Optimistic target level: 57.77

Arcellx Stock Forecast 06-28-2024.

Forecast target price for 06-28-2024: $55.94.
Negative dynamics for Arcellx shares will prevail with possible volatility of 4.462%.
Pessimistic target level: 54.61
Optimistic target level: 57.17

Arcellx Stock Forecast 06-29-2024.

Forecast target price for 06-29-2024: $56.43.
Positive dynamics for Arcellx shares will prevail with possible volatility of 2.545%.
Pessimistic target level: 55.75
Optimistic target level: 57.21

Arcellx Stock Forecast 06-30-2024.

Forecast target price for 06-30-2024: $57.63.
Positive dynamics for Arcellx shares will prevail with possible volatility of 3.369%.
Pessimistic target level: 57.02
Optimistic target level: 59.01

ACLX (ACLX) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jul. 60.72 57.80 65.77 12.12
Aug. 61.19 58.41 67.24 13.13
Sep. 58.25 54.46 62.18 12.42
Oct. 52.64 49.84 56.13 11.22
Nov. 51.55 48.73 54.36 10.35
Dec. 48.60 45.63 51.06 10.64

Arcellx forecast for this year


Arcellx Stock Prediction for Jul 2024

An uptrend is forecast for this month with an optimal target price of $60.7162. Pessimistic: $57.80. Optimistic: $65.77


Arcellx Stock Prediction for Aug 2024

An uptrend is forecast for this month with an optimal target price of $61.1898. Pessimistic: $58.41. Optimistic: $67.24


Arcellx Stock Prediction for Sep 2024

An downtrend is forecast for this month with an optimal target price of $58.2466. Pessimistic: $54.46. Optimistic: $62.18


Arcellx Stock Prediction for Oct 2024

An downtrend is forecast for this month with an optimal target price of $52.6433. Pessimistic: $49.84. Optimistic: $56.13


Arcellx Stock Prediction for Nov 2024

An downtrend is forecast for this month with an optimal target price of $51.5483. Pessimistic: $48.73. Optimistic: $54.36


Arcellx Stock Prediction for Dec 2024

An downtrend is forecast for this month with an optimal target price of $48.5997. Pessimistic: $45.63. Optimistic: $51.06



Arcellx (ACLX) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 51.82 47.51 55.26 14.02
Feb 48.45 45.93 49.84 7.84
Mar 47.57 45.47 51.34 11.44
Apr 46.15 43.81 47.71 8.17
May 41.83 40.09 45.20 11.31
Jun 41.34 38.60 44.67 13.59
Jul 43.60 42.18 47.17 10.57
Aug 48.36 43.39 51.63 15.95
Sep 53.39 50.68 57.83 12.36
Oct 49.99 47.26 54.93 13.96
Nov 49.73 46.04 51.02 9.76
Dec 51.41 46.93 53.01 11.47

Arcellx (ACLX) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 56.69 54.70 58.16 5.96
Feb 58.90 53.69 62.65 14.30
Mar 62.50 56.40 66.07 14.63
Apr 63.15 56.58 67.91 16.68
May 55.59 50.75 60.80 16.52
Jun 59.35 57.65 63.83 9.67
Jul 65.91 60.26 71.22 15.40
Aug 68.57 62.59 74.45 15.92
Sep 64.65 58.43 67.17 13.01
Oct 68.68 64.93 71.00 8.55
Nov 64.75 58.35 69.63 16.20
Dec 59.03 54.12 65.09 16.86

Arcellx (ACLX) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 52.43 50.11 57.20 12.39
Feb 53.93 49.09 56.17 12.61
Mar 55.68 51.26 58.65 12.59
Apr 57.63 54.34 59.28 8.34
May 58.16 55.51 59.82 7.20
Jun 57.02 55.10 62.66 12.07
Jul 53.69 49.99 55.71 10.27
Aug 60.25 55.63 65.03 14.45
Sep 56.57 53.48 58.85 9.12
Oct 49.95 48.07 53.52 10.19
Nov 46.57 44.09 49.48 10.89
Dec 45.00 41.55 48.51 14.35

Arcellx (ACLX) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 47.28 45.31 50.54 10.34
Feb 45.31 43.43 48.85 11.09
Mar 51.03 49.24 55.87 11.87
Apr 51.62 46.73 56.46 17.24
May 51.42 49.22 54.77 10.13
Jun 49.48 47.62 51.80 8.07
Jul 50.96 46.86 52.29 10.39
Aug 51.76 49.74 55.19 9.88
Sep 49.94 47.67 51.50 7.44
Oct 52.86 47.92 57.95 17.31
Nov 53.41 51.75 56.54 8.47
Dec 55.70 53.82 59.54 9.61

Arcellx information and performance

Arcellx Address

25 WEST WATKINS MILL ROAD, SUITE A, GAITHERSBURG, MD, US

Market Capitalization: 3 002 566 000 $

Market capitalization of the Arcellx, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ACLX shares in the company outstanding by the market price of one share.

EBITDA: -72 799 000 $

EBITDA of Arcellx is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -1.03

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: 1.192
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 22.57

Enterprise Value (EV) /Revenue

EV To EBITDA: -38.82

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 53503000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.